BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9020535)

  • 1. Delayed-type hypersensitivity skin reaction estimated with Multitest CMI in human giardiasis.
    Flisiak R; Prokopowicz D; Grzeszczuk A; Wiercińska-Drapało A
    Rocz Akad Med Bialymst; 1996; 41(2):239-44. PubMed ID: 9020535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical usefulness of Multitest in the evaluation of cellular immunity].
    Feijoó RM; Ardiles A; Lemp P; King A; Villamán JJ; Parra A; Silva M
    Rev Med Chil; 1996 Mar; 124(3):327-36. PubMed ID: 9008945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the U.S.A.
    Kniker WT; Anderson CT; McBryde JL; Roumiantzeff M; Lesourd B
    Ann Allergy; 1984 Feb; 52(2):75-82. PubMed ID: 6696298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhalative exposure to dioxins in wood preservatives on cell-mediated immunity in day-care center teachers.
    Wolf N; Karmaus W
    Environ Res; 1995 Feb; 68(2):96-105. PubMed ID: 7601078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunity in healthy and uremic adults assessed by in vivo and in vitro techniques. Validation of delayed hypersensitivity skin testing.
    López M; Jerez J; González M; Arias M
    Allergol Immunopathol (Madr); 1989; 17(1):21-8. PubMed ID: 2750637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
    Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed cutaneous hypersensitivity: multitest CMI reliability assessment in groups of volunteers.
    Murgueytio PU; Evans RG
    Ann Allergy; 1988 Dec; 61(6):463-5. PubMed ID: 3202336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4/CD8 lymphocytes in BALF during the efferent phase of lung delayed-type hypersensitivity reaction induced by single antigen inhalation.
    Grubek-Jaworska H; Hoser G; Droszcz P; Chazan R
    Med Sci Monit; 2001; 7(5):878-83. PubMed ID: 11535927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of Multitest CMI for the measurement of cell-mediated immunity in patients with bronchial asthma].
    Moniuszko T; Chyrek-Borowska S
    Pol Tyg Lek; 1989 Jul; 44(27):649-50. PubMed ID: 2637437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type IV immunity in alopecia areata in a comparison of 2 test methods].
    Lutz G; Niedecken H; Bauer R; Kreysel HW
    Z Hautkr; 1988 May; 63(5):391-2, 395-7. PubMed ID: 3261476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular immunity in patients with recurrent giardiasis].
    Collazo LE; Sotto A; González-Carbajal M; Ramos V
    Rev Cubana Med Trop; 1984; 36(2):233-43. PubMed ID: 6399603
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome.
    Murdoch JC
    N Z Med J; 1988 Aug; 101(851):511-2. PubMed ID: 3261407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence.
    Torres MJ; Mayorga C; Fernández TD; Cornejo-García JA; Antúnez C; Valenzuela M; Del Prado MF; Rodriguez-Pena R; Blanca M
    Int J Immunopathol Pharmacol; 2006; 19(1):119-30. PubMed ID: 16569350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis.
    Saint-Mezard P; Berard F; Dubois B; Kaiserlian D; Nicolas JF
    Eur J Dermatol; 2004; 14(3):131-8. PubMed ID: 15246935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in response to the multitest CMI skin test in the general population.
    Vine MF; Stein L; Weigle K
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):445-50. PubMed ID: 10795654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous delayed hypersensitivity in a French reference population using the cell-mediated immunity multitest device].
    Biron G; Roumiantzeff M; Ajjan N; Richard C; Tixier G; Serrou B
    Ann Anesthesiol Fr; 1981; 22(3):270-8. PubMed ID: 6117233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Giardiasis. Aspects of humoral and cellular immunity].
    Collazo Borrego LE; Sotto Escobar A; Expósito Rodríguez G; Arencibia Mérida I
    Rev Cubana Med Trop; 1989; 41(2):250-9. PubMed ID: 2486221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell mediated immunity in school children assessed by Multitest CMI skin testing II. Epidemiologic factors affecting immune responsiveness.
    Lesourd BM; Corriel RN; McBryde JL; Kniker WT
    Ann Allergy; 1985 May; 54(5):446-52. PubMed ID: 3994073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of cellular immunity in patients with bronchial asthma using the Multitest CMI].
    Wilewska-Kłubo T; Romański B
    Pol Tyg Lek; 1988 Oct 17-24; 43(42-43):1355-7. PubMed ID: 3252198
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser.
    Pozzilli P; Pagani S; Arduini P; Visalli N; Cioccia GP; Negri M; Andreani D
    Diabetes Res; 1987 Sep; 6(1):5-8. PubMed ID: 3500820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.